art_squared_logoThe unique patented design of the Aurora RTâ„¢ has been optimized and refined by the Linac MR Research group at the Cross Cancer Institute in Edmonton, Alberta Canada. This group started the Advanced Real Time Adaptive Radio Therapy (ART2) program in 2005 to take on the challenge of combining the proven cancer treatment capabilities of a Linear Accelerator with the soft tissue imaging capabilities of Magnetic Resonance Imaging.

This research is documented in the companion scientific website:

http://linac-MR.ca

The peer reviewed scientific publications can be found here.